203 related articles for article (PubMed ID: 11910826)
1. [Beta blockers for hypertension. No negative influence on insulin resistance].
MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
[No Abstract] [Full Text] [Related]
2. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
Sarafidis PA; Bakris GL
J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
[No Abstract] [Full Text] [Related]
3. [Hypertensive diabetic patients. Plus points for selective beta 1-blockade].
MMW Fortschr Med; 2001 Jun; 143(23):43-4. PubMed ID: 11460423
[No Abstract] [Full Text] [Related]
4. [The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].
Sawicki PT; Berger M
Dtsch Med Wochenschr; 1992 May; 117(22):875-9. PubMed ID: 1350758
[No Abstract] [Full Text] [Related]
5. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
[No Abstract] [Full Text] [Related]
6. [Heart failure studies are transferrable to everyday practice. No fear of beta blockers!].
MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494606
[No Abstract] [Full Text] [Related]
7. [Hypertension therapies compared. Are the new nevertheless better than the old?].
MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
[No Abstract] [Full Text] [Related]
8. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
[TBL] [Abstract][Full Text] [Related]
9. beta-Blockers and hypertension: a therapeutic reappraisal.
Panjrath GS; Sawhney S; Messerli FH
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):26-33. PubMed ID: 19667708
[TBL] [Abstract][Full Text] [Related]
10. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers and hypertension.
Cruickshank JM
J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
[No Abstract] [Full Text] [Related]
12. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
Lavie CJ; Messerli FH; Milani RV
J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
[No Abstract] [Full Text] [Related]
13. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
Traut
Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
[No Abstract] [Full Text] [Related]
14. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
[No Abstract] [Full Text] [Related]
15. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
[TBL] [Abstract][Full Text] [Related]
16. Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment.
Sein Anand J; Chodorowski Z; Hajduk A
Przegl Lek; 2005; 62(6):522-3. PubMed ID: 16225113
[TBL] [Abstract][Full Text] [Related]
17. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
Laurent S; Boutouyrie P
J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
[No Abstract] [Full Text] [Related]
19. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
[No Abstract] [Full Text] [Related]
20. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
Zidek W
MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
